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MaOBJECTIVES The aim of this study was to assess calcium growth with fused grayscale intravascular ultrasound (IVUS),
IVUS–virtual histology, and optical coherence tomography (OCT) from baseline to 5-year follow-up in patients
treated with bioresorbable vascular scaffolds.
BACKGROUND IVUS and OCT have individual strengths in assessing plaque composition and volume. Fusion of images
obtained using these methods could potentially aid in coronary plaque assessment.
METHODS Anatomic landmarks and endoluminal radiopaque markers were used to fuse OCT and IVUS images
and match baseline and follow-up.
RESULTS Seventy-two IVUS–virtual histology and OCT paired matched cross-sectional in- and out-scaffold segments
were fused at baseline and follow-up. In total, 46 calcified plaques at follow-up were detected using the fusion
method (33 in-scaffold, 13 out-scaffold), showing either calcium progression (52.2%) or de novo calcifications (47.8%).
On OCT, calcification volume increased from baseline to follow-up by 2.3  2.4 mm3 (p ¼ 0.001). The baseline
virtual histologic tissue precursors of dense calcium at follow-up were necrotic core in 73.9% and fibrous or fibrofatty
plaque in 10.9%. In 15.2%, calcium was already present at baseline. Precursors on OCT were lipid pool in 71.2%,
fibrous plaque in 4.3%, and fibrocalcific plaque in 23.9%.
CONCLUSIONS The use of OCT and IVUS fusion imaging shows similar calcium growth in- and out-scaffold segments.
Necrotic core is the most frequent precursor of calcification. The scaffold resorption process creates a tissue layer
that re-caps the calcified plaques. (Absorb Clinical Investigation, Cohort B [ABSORB B]; NCT00856856)
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ABBR EV I A T I ON S
AND ACRONYMS
BVS = bioresorbable vascular
scaffold
DC = dense calcium
GS = grayscale
IQR = interquartile range
IVUS = intravascular
ultrasound
NC = necrotic core
OCT = optical coherence
tomography
ROI = region of interest
VH = virtual histology
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1152C oronary atherosclerotic plaque char-acterization with intravascular im-aging is important for assessing
atherosclerosis, planning percutaneous coro-
nary interventions, and predicting outcomes
(1). Intravascular ultrasound (IVUS) and opti-
cal coherence tomography (OCT) are the 2
most widely used intracoronary imaging
techniques.
The main advantage of IVUS lies in its
deep penetration ability, which offers a cross
section of the entire vessel wall and allows
the detection of deep calcification. Its main
disadvantages are limited resolution and the
strong reflection of the ultrasound waves byendoluminal calcium, which creates a shadow behind
the calcium that precludes assessment of the extent
and depth of calcification (2).SEE PAGE 1162IVUS–virtual histology (VH) increases the useful-
ness of IVUS by characterizing tissue components and
allowing better risk stratification (1). However, stent
and scaffold struts are incorrectly recognized as
dense calcium (DC) surrounded by necrotic core (NC)
on VH. Moreover, the VH algorithm also incorrectly
inputs fibrofatty signal in the shadow behind
DC (3,4).
OCT enables a detailed assessment of near-lumen
plaque characteristics because of its high resolution
(10 to 20 mm), including features related to plaque
vulnerability such as thin fibrous caps. OCT can
also assess calcifications more accurately because
the light can cross calcified areas without being
excessively reflected and without substantial atten-
uation, allowing visualization of the real extent of
calcification plaque along its longitudinal and axial
distribution, at least in the relatively superficial
layer of the vessel wall (5). However, the high reso-
lution comes at the cost of limited depth of pene-
tration (6). Therefore, OCT is unable to detect deep
calcium.
The feasibility and advantages of combining the
individual strengths of both technologies in vivo have
been described (7). The feasibility of off-line fusion
images of coregistered IVUS and OCT has been pre-
viously described (8).
The objective of the present study was to compre-
hensively assess the serial progression of calcification
at 5-year follow-up after bioresorbable vascular scaf-
fold (BVS) implantation using matched fusion images
from IVUS and OCT. We sought to evaluate calcium
progression and describe the baseline tissue pre-
cursors of calcification at long-term follow-up.METHODS
STUDY DESIGN. In Cohorts B1 and B2 from ABSORB
(Absorb Clinical Investigation) (n ¼ 101), 28 patients
with 29 lesions underwent IVUS and OCT assessment
at baseline and 5 years (9) (Online Figure 1). OCT,
grayscale (GS)–IVUS, and IVUS-VH images were dis-
played simultaneously and screened concomitantly
frame by frame to match using radiopaque markers
and/or anatomic marks at each time point (Online
Figure 2). Then the matched cross sections selected
were colocalized between 2 time points. Each cross
section was subdivided into 4 quadrants, and the
presence of each type of atherosclerotic plaque was
assessed in each quadrant (7).
GS-IVUS ACQUISITION. Post-implantation and 5-year
images were obtained using 20-MHz, phased-array
IVUS catheters (Eagle Eye, Volcano, Rancho Cor-
dova, California) using an automated pull-back of
0.5 mm/s. Semiautomatic detection of both lumen
and external elastic membrane was performed using
QCU-CMS-Research software version 4.69 (Medis
Medical Imaging, Leiden, the Netherlands). Calcifi-
cation on GS-IVUS was defined as bright echoes with
acoustic shadowing (2).
IVUS RADIOFREQUENCY ANALYSIS. On IVUS-VH
analysis, “pseudo” DC or NC related to the scaffold
strut was defined as confluent, uninterrupted white
color surrounded by red color, located near the lumen
contour. DC located behind the struts and separated
from the struts was considered as real DC at baseline
(10). The “white color” was then defined as calcifica-
tion if the confluent white-color area exceeded
0.0625 mm2 (0.25  0.25 mm), considering the reso-
lution of the 20-MHz IVUS catheters used in the study
(2). To determine the major baseline tissue precursor
of calcifications at 5 years, fusion images weighting
VH information in topographically matched calcified
areas at follow-up were used. The baseline VH tissue
precursor was determined as the major tissue compo-
nent, if it constituted approximately 50% of the total
tissue.
OCT IMAGE ACQUISITION AND ANALYSIS. OCT
acquisition was performed using C7/C8 frequency
domain systems (Light Lab Imaging, Westford, Mas-
sachusetts) (11). The OCT images acquired at baseline
and follow-up were analyzed off-line at 100- or
200-mm longitudinal intervals within the region of
interest (ROI) using QCU-CMS.
Three tissue components were identified on the
basis of consensus of 5 analysts: fibrous, fibrocalcific,
and lipid pool (lipid or NC) (11) (Online Appendix).
The baseline OCT tissue precursor of calcifications at
FIGURE 1 Matching and Fusion Method in ABSORB Cohort B
The yellow asterisk indicates the side branch. Two calcifications are shown at the ostium of the side branch. Images A to C show the matched
optical coherence tomography (OCT), grayscale (GS) intravascular ultrasound (IVUS), and IVUS–virtual histology (VH) images using the side
branches and 2 calcifications as anatomic landmarks. The green color (fibrofatty) in C is an artifact of the VH measurement: the ultrasound
waves are completely reflected by the calcium, and there is basically no backscattering signal stemming from the shadow area located
behind the main ultrasound reflection. Images A0 and B0 show the fusion images of OCT and GS-IVUS and of OCT and IVUS-VH, respectively.
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1153follow-up was defined as the tissue component
constituting approximately 50% in topographically
matched calcified area.
MATCHING CROSS SECTION AND ROI DEFINITION. The
matching of multimodalities at 1 time point and at
follow-up is performed according to the following
criteria: the presence of platinum marker (BVS) and
common anatomic landmarks such as side branch,
vein, pericardium, position and configuration of
calcified plaque, characteristic lumen shape and
circumferential profile of plaque thickness, and/or
positional or directional relationship among all these
landmarks (Figure 1). The following cross section is
not included in the analysis (Online Appendix). The
ROI was defined as the scaffold segment and 5 mm
proximal and distal.
FUSION CROSS SECTION OF IVUS AND OCT. The
principles of fusion imaging have been previously
described (8). In summary, the matched GS-IVUS,
IVUS-VH, and OCT images were adjusted and fusedin Adobe Photoshop Elements 12 (Adobe Systems, San
Jose, California) (Figure 1). Detailed processes were as
follows.
First, the sizes of OCT and IVUS images were
adjusted by matching the 1-mm calibration line. The
original square shape of both IVUS and OCT images
was well defined, so that matching of the 1-mm cali-
bration line between OCT and IVUS images was
maintained, thus allowing matching of square image
areas.
Second, the 2-dimensional cross-sectional images
were rotated using cross-sectional landmarks ac-
cording to the following hierarchy: 1) side branch; 2)
calcification; 3) lumen shape; and 4) circumferential
plaques.
Third, to optimize the overlay of IVUS on top of
OCT images, the transparency function of Photoshop
Elements was used to allow simultaneous visibility of
the structures in the underlying OCT images. As a
suitable default setting for overlaying IVUS on top of
OCT images, transparency of 60% to 70% for the
FIGURE 2 Assessment of Calcification: Calcium Area Was Characterized by the Appearance of Signal-Poor Heterogeneous Images
With Sharp Borders
Calcium arc (yellow) was measured from the gravitational center of the lumen to the 2 lateral extremities of the calcium. Calcium axial length
(white dashed line) in each cross section was measured as the maximal geometric length. The maximal (green), minimal (red), and mean cap
thickness overlying calcification were measured.
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images was applied.
CALCIUM ASSESSMENT BY FUSION IVUS AND
OCT. To assess the diagnostic accuracy of calcium
detection of each individual modality compared with
the fusion images, the cross sections of each modality
were evaluated by 3 teams of 2 cardiologists who were
blind to the images of the other modalities at baseline
and 5 years using the criteria described earlier.
After having assessed individually the presence or
absence of calcification in each imaging modality, a
group of 5 cardiologists assessed by consensus the
diagnosis of calcification in the matched cross sec-
tion. Calcification was diagnosed by fusion when
qualitative and quantitative criteria were met by at
least 2 imaging modalities. Sensitivity and specificity
of each modality were determined using the fusion
image as comparator.
OCT AND IVUS CALCIFICATION MEASUREMENTS. The
following OCT parameters were assessed (Figure 2):
calcium area, volume, arc, axial and longitudinal
length, and intima thickness overlying calcifications
(12); calcium volume was calculated on the basis of
the disk summation method (Online Appendix).
AUTOMATIC QUANTITATIVE ECHOGENICITY
ANALYSIS. Echogenicity classifies plaque compo-
nents into 5 categories on the basis of their gray-levelintensity on IVUS: calcified, upper-echogenic,
hyperechogenic, hypoechogenic, and unknown (13).
STATISTICAL ANALYSIS. Continuous variables are
presented as mean  SD or as median and interquartile
range (IQR) as appropriate and were compared using
the paired Student t test or Wilcoxon signed rank test
for baseline versus follow-up comparisons and the
independent Student t test and Mann-Whitney U test
for in- versus out-scaffold. Binary variables are sum-
marized as counts and percentages and were
compared using the chi-square or Fisher exact test. For
each imaging modality alone, sensitivity and speci-
ficity for calcium detection were determined using the
fusion method as the comparator. Agreement for cal-
cium detection between each modality and the fusion
method was assessed using the Cohen k statistic.
Because the data in the study hadmultilevel structure,
a mixed-effects model was used. Patients were
implemented as the random effect, and in- or out-
scaffold segment was input as the fixed effect. A 2-
sided p value <0.05 indicated statistical significance.
All analyses were performed using SPSS version 22
(IBM, Armonk, New York).
RESULTS
STUDY POPULATION AND CASE SELECTION. Among
28 patients with complete 5-year follow-up in the
TABLE 1 Baseline Patient Characteristics (15 Patients,
16 Lesions)
Age, yrs 59.14  7.16
Male 9 (60.0)
Hypertension requiring medication 8 (53.3)
Hypercholesterolemia requiring medication 9 (60.0)
Diabetes mellitus requiring medication 0 (0.0)
Myocardial infarction history 4 (26.7)
Cardiac intervention history 2 (13.3)
Current smokers 4 (26.7)
Family history of CHD 10 (66.7)
Clinic presentation
Stable 12 (80.0)
Non-ST-segment elevation ACS 1 (6.7)
Silent ischemia 0 (0.0)
Target vessel
Left anterior descending coronary artery 9 (56.2)
Left circumflex coronary artery 3 (18.8)
Right coronary artery 4 (25.0)
AHA/ACC lesion classification
Type A 0 (0.0)
Type B1 11 (68.8)
Type B2/C 5 (31.3)




Lipid profile at 5 yrs (mmol/l)
Total cholesterol 3.7  0.7
LDL 1.6  0.5
HDL 1.0  0.3
Triglyceride 2.3  0.4
Values are mean  SD or n (%).
ACC ¼ American College of Cardiology; ACS ¼ acute coronary syndrome;
AHA ¼ American Heart Association; CHD ¼ coronary heart disease;
HDL ¼ high-density lipoprotein; LDL ¼ low-density lipoprotein.
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1155ABSORB Cohort B trial, 15 (16 lesions) with all 3 im-
aging modalities (GS-IVUS, IVUS-VH, and OCT)
available were included in the present analysis.
Baseline clinical characteristics of the study popula-
tion are summarized in Table 1, and IVUS measure-
ments at baseline and 5 years are shown in Table 2.
Patients imaged with time-domain OCT were
excluded from the analysis (Online Figure 1).
In the 16 coronary lesions, at baseline, 72 cross
sections (4.6  1.4 cross sections per lesion) of each of
the 3 imaging modalities (IVUS, IVUS-VH, and OCT)
were matched and fused using the criteria stated
earlier. These fused cross sections were further
matched with the corresponding 72 fused cross sec-
tions from the 5-year follow-up assessment. These
constituted the study database of 72 pairs of matched,
fused (GS-IVUS, IVUS-VH, and OCT) cross sections.
No calcification was observed in 33 of these 72 pairs
of cross sections (41.8%) (i.e., at neither time point).
In the other 39 pairs of fused cross sections (58.2%),
46 calcified area pools were detected at 5-year follow-
up. These 46 calcified area pools represented either
calcium progression from baseline (n ¼ 24) or de novo
calcification (n ¼ 22) (Figure 3).
Of note, calcium was detected by VH only at base-
line in 22 cross sections. To definitively determine the
true significance of this isolated VH signal, follow-up
fusion images were assessed, and calcification was
confirmed in 13 of 22 cross sections. In the remaining 9
cross sections, the VH signal of calcification either
disappeared or persisted only as an isolated VH signal
not confirmed by the fusion method.
DIAGNOSTIC ACCURACY OF CALCIFICATION WITH
FUSION AND INDIVIDUAL MODALITIES. Table 3
shows the sensitivity and specificity of each modality
in detecting calcium at 2 time points, using the fusion
modality as the comparator.
ANALYSIS OF TISSUE PRECURSOR OF CALCIFICATION ON
OCT AND IVUS-VH. On IVUS-VH, the tissue precursors
of DC at baseline were NC (n ¼ 34 [73.9%]) and fibrous
or fibrofatty plaque (n ¼ 5 [10.9%]). In the remaining
7 calcifications (15.2%), calcium was already present
at baseline. On OCT, precursors were lipid pool
(n ¼ 33 [71.2%]), fibrous plaque (n ¼ 2 [4.3%]), and
fibrocalcific tissue (n ¼ 11 [23.9%]).
OCT CALCIUM MEASUREMENTS. An overall increase
in calcium area was observed both in-scaffold
(D ¼ 0.37 mm2; IQR: 0.25 to 0.74 mm2) and
out-scaffold (D ¼ 0.39 mm2; IQR: 0.21 to 1.2 mm2)
(p ¼ 0.098, in- vs. out-scaffold). The mixed-effects
model showed a similar trend (p ¼ 0.117).
Serial changes in intima thickness overlying the
calcified plaque as well as axial calcium length andarc were analyzable in 14 plaques (9 in- and 5 out-
scaffold) at both time points. Minimal intima thick-
ness overlying calcium increased significantly more
for in-scaffold (D ¼ 180  152 mm) than out-scaffold
(D ¼ 16  116 mm) segments (p ¼ 0.034, in- vs. out-
scaffold), although it was statistically nonsignificant
(p ¼ 0.079) after mixed-effects analysis. Overall, the
mean intima thickness, maximal intima thickness,
axial calcium length, and arc significantly increased
at follow-up, with no differences between in- and
out-scaffold segments before and after using the
mixed-effects model (Table 4).
Longitudinal calcium length (1.8  0.71 mm at
baseline vs. 3.6  2.0 mm at 5 years; p ¼ 0.003) and
volume (0.83  0.64 mm3 at baseline vs. 3.1  2.5 mm3
at 5 years; p ¼ 0.001) significantly increased at
follow-up.
IVUS CALCIFICATION ARC MEASUREMENTS. GS-IVUS
detected calcium at both time points in 21 plaques. An
TABLE 2 Intravascular Ultrasound Measurements at Baseline and 5-Year Follow-Up
Baseline
5-Year
Follow-Up Difference p Value
Scaffold segment (16 paired measurements)
Vessel area, mm2 14.4 (13.0 to 16.8) 14.2 (11.5 to 15.5) 0.6 (1.3 to 0.36) 0.121
Luminal area, mm2 6.4 (5.8 to 7) 6.3 (5.9 to 7.2) 0.15 (0.24 to 0.88) 0.352
Plaque area, mm2 8.4 (6.6 to 10.0) 7.4 (6.2 to 8.5) 0.82 (1.5 to 0.24) 0.044
Plaque burden, % 55.8  5.8 52.8  6.1 3.0  6.7 0.094
Proximal edge (7 paired measurements)
Vessel area, mm2 13.5 (12.4 to 14.9) 13.1 (12.1 to 14.8) 0.28 (1.0 to 0.06) 0.128
Luminal area, mm2 8.4 (6.2 to 8.8) 6.2 (5.8 to 8.0) 0.76 (1.1 to 0.0) 0.091
Plaque area, mm2 6.1 (5.8 to 6.2) 6.8 (6.3 to 7.7) 0.54 (0.05 to 0.74) 0.176
Plaque burden, % 43.7  10.3 51.4  6.0 7.8  14.9 0.219
Distal edge (9 paired measurements)
Vessel area, mm2 11.1 (9.2 to 15.9) 11.4 (9.9 to 15.0) 0.31 (0.68 to 0.64) 0.767
Luminal area, mm2 6.3 (5.1 to 7.1) 5.7 (5.0 to 6.8) 0.07 (1.1 to 0.43) 0.515
Plaque area, mm2 5.1 (4.2 to 8.4) 5.2 (4.8 to 7.8) 0.01 (1.2 to 1.6) 0.953
Plaque burden, % 46.5  14.9 51.2  4.8 4.6  13.5 0.334











Zeng et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 0 , N O . 1 0 , 2 0 1 7
Calcification After Bioresorbable Vascular Scaffold Implantation O C T O B E R 2 0 1 7 : 1 1 5 1 – 6 1
1156overall increase in calcium arc was observed, with no
difference between in-scaffold (D ¼ 16  13) and out-
scaffold (D ¼ 35  28) segments (p ¼ 0.134, in- vs.
out-scaffold), and a similar trend was observed after
mixed-effects analysis (p ¼ 0.075) (Table 4).rt for Cross Section Selection
72 matched cross sections analyze
with 79 plaques detected by usi
affold segment at BL and FUP
ed cross sections with 55 plaques
ce of calcium at BL or FUP
 sections with 22 plaques
Evidence of calcium at FUP*









ction (79 pools) matched for grayscale intravascular ultrasound (IVUS), IVUS–
up were analyzed. *No calcification was observed at baseline (BL) that was pCALCIUM ASSESSMENT WITH IVUS ECHOGENICITY. IVUS
echogenicity was evaluated in 39 cross sections con-
taining 46 calcified area pools. An increase in calcium
area was observed, with no difference between in-
scaffold (D ¼ 0.21 mm2; IQR: 0.1 to 0.28 mm2) and
out-scaffold (D ¼ 0.22 mm2; IQR: 0.03 0.37 mm2)
segments (p ¼ 0.881, in- vs. out-scaffold); after
applying the mixed-effects model, p ¼ 0.887 (Online
Table 1).
DISCUSSION
The findings of the present study can be summarized
as follows: 1) fusion OCT and IVUS images provide a
comprehensive assessment of coronary artery calci-
fication; 2) calcification progresses to a similar extent
in in-scaffold and out-scaffold segments, suggesting
that calcification is a global phenomenon not influ-
enced by the presence of the scaffold; 3) the intima
thickness overlying calcium in-scaffold is thicker
than out-scaffold segments and may constitute a new
endoluminal lining isolating the calcified plaque from
the lumen; 4) IVUS-VH has high sensitivity for the
detection of calcification; and 5) lipid pool and NC are
the most frequent precursors of calcifications at
follow-up.d at BL and FUP
ng IVUS-OCT
Out-scaffold segment at BL and FUP
atched cross sections with 24 plaques
No evidence of calcium at BL or FUP
11 cross sections with 11 plaques
Evidence of calcium at FUP*





virtual histology, and optical coherence tomography (OCT) images at
resent at follow-up (FUP).
TABLE 3 Diagnostic Accuracy of Individual Optical Coherence Tomography,
Grayscale Intravascular Ultrasound, and Intravascular Ultrasound–Virtual Histology for
the Calcification Detection of Coronary Atherosclerotic Plaque at Baseline and
5-Year Follow-Up: Comparison With Fusion Method
Sensitivity, % Specificity, % k p Value
Pooled baseline and 5-yr
OCT OCT() OCT(þ)
Fusion() 88 0 70.0 100.0 0.722 <0.001
Fusion(þ) 21 49
GS-IVUS GS-IVUS() GS-IVUS(þ)
Fusion() 88 0 95.7 100.0 0.961 <0.001
Fusion(þ) 3 67
IVUS-VH IVUS-VH() IVUS-VH(þ)




Fusion() 55 0 58.3 100.0 0.661 <0.001
Fusion(þ) 10 14
GS-IVUS GS-IVUS() GS- IVUS(þ)
Fusion() 55 0 87.5 100.0 0.907 <0.001
Fusion(þ) 3 21
IVUS IVUS-VH() IVUS-VH(þ)




Fusion() 33 0 76.1 100.0 0.727 <0.001
Fusion(þ) 11 35
GS-IVUS GS-IVUS() GS-IVUS(þ)
Fusion() 33 0 100.0 100.0 1.00 <0.001
Fusion(þ) 0 46
IVUS-VH IVUS-VH() IVUS-VH(þ)
Fusion() 29 4 100.0 87.9 0.894 <0.001
Fusion(þ) 0 46
Values are n (%).
GS ¼ grayscale; IVUS¼ intravascular ultrasound; OCT ¼ optical coherence tomography; VH ¼ virtual histology.
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1157CALCIFICATION DETECTION WITH FUSION OF OCT
AND IVUS. Coronary artery calcium affects the path-
ophysiologic development of atherosclerosis and
triggers cardiac events. In addition, its severity and
endoluminal topography affect interventional strat-
egy and clinical events (14). In the present study,
calcification was evaluated by fusion of OCT, GS-
IVUS, and IVUS-VH, which improved the diagnostic
accuracy of calcification by combining the individual
strengths of each modality. As for the diagnostic ac-
curacy of individual modalities in detecting calcifi-
cation, GS-IVUS at baseline showed lower sensitivity
than IVUS-VH, which could be explained by the fact
that the complex classification tree and algorithm for
tissue analysis on IVUS-VH relies on backscattering of
the radiofrequency signal, whereas GS-IVUS detects
only the envelope of the ultrasonic signal.
In this analysis, the specificity of OCT was high, but
the sensitivity was limited. Among possible reasons
for the low sensitivity are the limited penetration of
OCT, which precludes the detection of deep calcium
deposits, guidewire artifacts, and tangential signal
dropout.
IVUS-VH, however, showed 100% sensitivity and
low specificity for calcium detection. Some isolated,
localized IVUS-VH DC signals at baseline were
considered artifacts when not confirmed by grayscale
and/or OCT calcium detection. Interestingly, some of
these isolated VH signals (13 of 22) became fully
calcified plaques at follow-up in the same topographic
area detected using the fusion method (Figure 4). This
unexpected finding might reopen the debate on the
diagnostic value of IVUS-VH for the detection of cal-
cium (15,16). The validation study with IVUS-VH ob-
tained from 45-MHz rotation IVUS has demonstrated
the capacity of the VH algorithm to detect micro-
calcification in ROIs as small as 0.25  0.25 mm (3).
CALCIFIED PLAQUE DEVELOPMENT AND PRECURSORS.
In the present study, calcifications (calcium area, arc,
axial length, calcified echogenicity) were shown to
increase to a similar extent in both in- and out-
scaffold segments. This implies a global calcification
phenomenon unrelated to the implantation of the
scaffold. Calcium progression has been shown in
patients on secondary prevention and statin treat-
ment (17). This natural history is thought to reflect a
plaque-stabilizing phenomenon associated with lipid-
lowering therapy (18).
Previous data have shown indirectly that at follow-
up, atherosclerosis regresses by decreasing its NC
content and increasing its DC content on average
(17–19). Our study is the first to date to clearly and
directly demonstrate that phenomenon at the plaqueand cross section level. Only by this meticulous
paired, matched analysis of in vivo data with long-
term follow-up were we able to demonstrate the
transformation of NC into calcium, as the vast ma-
jority of tissue precursors were NC or lipid pool. The
molecular mechanisms for this transformation remain
largely unclear, but “mineral deposit,” “osteoprote-
gerin,” and efferocytosis of macrophage are the
possible mechanisms (20,21). Coregistration of mul-
tislice computed tomography and fluoride-18 posi-
tron emission tomography has clearly demonstrated
dynamic and inflammatory changes in calcified le-
sions. Fluoride is taken up by macrophages, lipo-
somes, and microcalcification. In addition, NC on
IVUS-VH has been colocalized with calcification
visualized by multislice computed tomography and
fluoride-18 positron emission tomography (22).
TABLE 4 Evolution From Baseline to 5-Year Follow-Up of 46 Calcifications Detected by Fusion at Follow-Up in 39 Cross Sections
Baseline 5-Year Difference p Value
Calcium area (n ¼ 46) measured on OCT in de novo or progressed calcifications
Calcium area, mm2
In-scaffold (n ¼ 33) 0.22  0.32 0.70  0.41 0.48  0.32 <0.001
Out-scaffold (n ¼ 13) 0.19  0.30 1.04  1.14 0.85  1.0 0.003
p value, in- vs. out-scaffold 0.774 0.199 0.098
n ¼ 14 progressed calcifications detectable on OCT
Minimal intima thickness overlying calcium, mm
In-scaffold (n ¼ 9) 92  53 272  149 180  152 0.002
Out-scaffold (n ¼ 5) 223  156 239  119 16  116 0.345
p value, in- vs. out-scaffold 0.031 0.629 0.034
Maximal intima thickness overlying calcium, mm
In-scaffold (n ¼ 9) 303 (181–480) 355 (254–519) 95 (40–283) 0.209
Out-scaffold (n ¼ 5) 248 (141–333) 278 (204–447) 55 (24–87) 0.345
p value, in- vs. out-scaffold 0.482 0.274 0.16
Mean intima thickness overlying calcium, mm
In-scaffold (n ¼ 9) 217  117 361  183 144  141 0.005
Out-scaffold (n ¼ 5) 238  111 265  109 27  38 0.147
p value, in- vs. out-scaffold 0.721 0.310 0.066
Arc on OCT, 
In-scaffold (n ¼ 9) 30  13 46  17 16  14 0.003
Out-scaffold (n ¼ 5) 34  24 70  19 36  30 0.03
p value, in- vs. out-scaffold 0.694 0.139 0.057
Axial length, mm
In-scaffold (n ¼ 9) 0.89 (0.51–1.08) 1.1 (0.64–1.4) 0.42 (0.17–0.77) 0.002
Out-scaffold (n ¼ 5) 0.53 (0.38–0.79) 0.95 (0.70–1.2) 0.45 (0.1–1.2) 0.028
p value, in- vs. out-scaffold 0.261 0.936 0.851
Calcium volume and longitudinal length assessed in 13 progressed calcifications detectable on OCT*
Longitudinal length, mm (n ¼ 13) 1.8  0.71 3.6  2.0 1.7  2.0 0.003
Volume, mm3 (n ¼ 13) 0.83  0.64 3.1  2.5 2.3  2.4 0.001
n ¼ 21 progressed calcifications detectable on IVUS
Arc on IVUS, deg
In-scaffold (n ¼ 16) 43  21 59  23 16  13 0.002
Out-scaffold (n ¼ 5) 34  24 69  31 35  28 0.018
p value, in- vs. out-scaffold 0.350 0.442 0.134
Fourteen progressed calcifications detectable on OCT and 21 detectable on grayscale IVUS at both time points. Values are mean  SD or median (interquartile range).
*Thirteen separate calcified volumes were quantified by OCT; 2 continuous calcified cross sections belong to one continuous calcified volume.
IVUS ¼ intravascular ultrasound; OCT ¼ optical coherence tomography.
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1158Regulatory bodies in Europe and the United States
have raised concerns over bioresorption of fully bio-
resorbable scaffold in polylactide: local acidification
and transient detection (Von Kossa staining) of
calcification around the degraded scaffold strut
have been reported in preclinical models as early
as 28 days but had disappeared at long-term follow-
up (23). Despite these reassuring preclinical data,
clinicians remain concerned by the long-term out-
comes of polylactide bioresorbable scaffolds. For
instance, in preclinical studies, it has been demon-
strated that metallic bioresorbable scaffolds in
magnesium evolve into soft amorphous hydroxyap-
atite of calcium (24).
The progression and development of new
calcified plaque should not be confused withneoatherosclerosis, whose OCT features are very
specific (25). It must be emphasized that the luminal
area in the present series was 6.4 mm2 at baseline and
6.3 mm2 at 5 years, with no sign of restenosis or
luminal encroachment (Table 2).
RE-CAPPING OF THE CALCIFIED PLAQUE. Despite
the appearance and progression of calcifications, the
new lesions could be considered stable for the
following reasons: at 5-year follow-up, a moderately
thick layer of neointima (272  149 mm) is located on
top of each calcified plaque in-scaffold segment
(Figures 4D and 4F0). The minimal intima thickness
overlying the calcification increased significantly
more in in-scaffold segments at 5-year follow-up
compared with out-scaffold segments. The term
FIGURE 4 Serial Analyses of a Calcification by Fusion of Optical Coherence Tomography and Intravascular Ultrasound Images at Baseline and Follow-Up
The yellow arrow indicates the platinum marker at 6 o’clock. Images A to C show the matched cross section of optical coherence tomography (OCT), grayscale (GS)
intravascular ultrasound (IVUS), and IVUS–virtual histology (VH) at baseline, whereas images D to F show matched cross sections at follow-up. Image A, at 1 to
5 o’clock, shows a lipid-pool plaque with low light intensity, high light attenuation, and an unclear border. Image (C) shows mixed plaque composition of necrotic core,
fibrous tissue, and dense calcium; struts on IVUS-VH are identified as pseudo dense calcium. Images (A0) and (B0) show the fusion of OCT and GS-IVUS and of OCT and
IVUS-VH, respectively. Image C0 emphasizes the VH information of image B0 by selecting a lower threshold of transparency. The calcium spot with sharp borders (D)
corresponds to the lipid-rich plaque on image A. Images D0 and E0 show the fusion of OCT and GS-IVUS and of OCT and IVUS-VH, respectively. Image F0 emphasizes the
VH information of image E0 by selecting a lower threshold of transparency. Image G shows the echogenicity analysis behind the strut at baseline, upper-echogenicity
with light blue color progressed to calcium at follow-up (H; white). The color legend for each echogenicity classification is provided.
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1159“re-capping of the plaque” has been coined to
describe this phenomenon (12).
This “cap” overlying the calcification is likely due
to the integration of the polymeric struts into the
vessel wall, which isolates the lumen from the un-
derlying calcium and the surrounding lipid and NC.
The “cap” may transform the unstable phenotype of
plaque to a stable one by covering the calcific spots
and thin-cap fibroatheroma with neointima (12);
furthermore, calcium with a homogenous thick cap
will have less effect on the shear stress than spotty
superficial calcium (26).STUDY LIMITATIONS. This study represents the
longest natural history of evolution of plaques
analyzed serially by fusion IVUS and OCT. There were
nevertheless some methodological limitations. First,
precise and careful matching of images acquired with
a sampling rate as different as 1 frame/s from VH to
100 or 180 frames/s for OCT considerably reduces the
number of analyzable cross sections per lesion. The
goal of the study was not to unravel clinical implica-
tions but to generate hypotheses. Therefore caution
should be exercised when extrapolating the study
results given the limited number of cross sections.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Both
OCT and IVUS alone have limitations in evaluating
calcification. In this study, by fusing OCT and IVUS, we
have shown that similar calciumgrowth in in-scaffold and
out-scaffold segments in patients treated with BVS. NC is
the most frequent precursor of calcification.
TRANSLATIONAL OUTLOOK: In the future, coregis-
tration of OCT and IVUS techniques (e.g., acquisition with
hybrid catheters) will likely be in clinical practice. Future
research is needed to definewhether calcification is a sign
of plaque progression or stabilization of coronary
atherosclerosis. Remaining questions include ascertaining
the molecular mechanism and determining how to use
pharmacological intervention targeting calcification to
stabilize the plaque.
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1160Second, the lack of intracoronary images pre-
procedure renders the analysis of true tissue compo-
sition more complex, because strut artifacts are
detected as “pseudo” DC and NC on IVUS-VH images.
To account for that, we excluded struts from the
IVUS images according to a previously validated
method (10).
Third, we did not use any automated imaging
software specifically validated to create fused images.
Therefore, the display of the presented images is
purely exploratory but may serve as a preamble for
further development of dedicated software applica-
tion on imaging on the basis of photoacoustic systems
(27), as well as hybrid technique (28).
Fourth, the data on lipid profiles and medications
in this study were collected as general clinical infor-
mation. It was clearly stipulated in the protocol
that the investigators had to follow the guidelines
of the European Society of Cardiology (at the
time of the trial design, target low-density lipoprotein
<2 mmol/l). In the present study at 5 years, 14 of 15
patients were treated with hydroxymethylglutaryl
coenzyme-A reductase inhibitors (3 with rosuvasta-
tin, 7 with atorvastatin, and 5 with simvastatin). Low-
density lipoprotein was well controlled and
decreased from baseline (2.6  0.5 mmol/l) to 5 years
(1.6  0.5 mmol/l). All 15 patients presented with at
least 1 calcification in the selected 72 fused cross
sections. The limited number of observations does
not allow any physiopathological or pharmacological
interpretation.
Fifth, our findings are limited to segments treated
with BVS and cannot be extrapolated to segments
treated with metallic stents or untreated ones. Of
note, because the struts get resorbed at about 2 years
of follow-up, we can speculate that at 5 years, the
behavior of the vascular wall should be close to that
of an untreated segment.
Finally, because no validation against histologic
findings was performed, our results should be
cautiously interpreted as hypothesis generatingregarding the potential benefits of hybrid imaging
techniques.
CONCLUSIONS
With the use of OCT and IVUS fusion imaging, we
demonstrate in vivo similar calcium growth in in-
scaffold and out-scaffold segments in patients
treated with BVS. NC is the most frequent precursor
of calcification. The scaffold resorption process
creates a tissue layer that re-caps calcified plaques.
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